2.02
-0.09 (-4.50%)
| Previous Close | 2.11 |
| Open | 2.09 |
| Volume | 2,530,299 |
| Avg. Volume (3M) | 5,776,693 |
| Market Cap | 297,665,888 |
| Price / Sales | 0.860 |
| Price / Book | 0.690 |
| 52 Weeks Range | |
| Earnings Date | 7 Feb 2025 |
| Profit Margin | -201.27% |
| Operating Margin (TTM) | -33.63% |
| Diluted EPS (TTM) | -4.94 |
| Quarterly Revenue Growth (YOY) | -9.50% |
| Total Debt/Equity (MRQ) | 120.38% |
| Current Ratio (MRQ) | 1.39 |
| Operating Cash Flow (TTM) | -160.26 M |
| Levered Free Cash Flow (TTM) | -29.27 M |
| Return on Assets (TTM) | -4.39% |
| Return on Equity (TTM) | -93.03% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Canopy Growth Corporation | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.17 |
|
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| % Held by Insiders | 0.13% |
| % Held by Institutions | 6.26% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Parallax Volatility Advisers, L.P. | 30 Sep 2024 | 276,870 |
| Engineers Gate Manager Lp | 30 Sep 2024 | 121,422 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |